Chemotherapy for ovarian cancer - a consensus statement on standard practice

Metadata

Authors/Creators:	Adams, M. Calvert, A.H. Carmichael, J. Clark, P.I. Coleman, R.E. https://orcid.org/0000-0002-4275-1043 Earl, H.M. Gallagher, C.J. Ganesan, T.S. Gore, M.E. Graham, J.D. Harper, P.G. Jayson, G.C. Kaye, S.B. Ledermann, J.A. Osborne, R.J. Perren, T.J. Poole, C.J. Radford, J.A. Rustin, G.J.S. Slevin, M.L. Smyth, J.F. Thomas, H. Wilkinson, P.M.
Copyright, Publisher and Additional Information:	© 1998 Cancer Research UK. This article is available under the terms of the Creative Commons Licence, Attribution-Non-Commercial-Share-Alike 3.0 http://creativecommons.org/licenses/by-nc-sa/3.0/.
Keywords:	Paclitaxel taxol; phase-ii; cisplatin; trial; carcinoma
Dates:	Published: December 1998
Institution:	The University of Sheffield
Academic Units:	The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield) The University of Sheffield > Sheffield Teaching Hospitals
Depositing User:	Symplectic Sheffield
Date Deposited:	13 Dec 2016 10:23
Last Modified:	13 Dec 2016 10:34
Published Version:	http://dx.doi.org/10.1038/bjc.1998.699
Status:	Published
Publisher:	Cancer Research UK
Refereed:	Yes
Identification Number:	https://doi.org/10.1038/bjc.1998.699

CORE (COnnecting REpositories)